Clinical trials
Completed Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,779 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 58 |
| 2001 | 46 |
| 2002 | 70 |
| 2003 | 93 |
| 2004 | 106 |
| 2005 | 122 |
| 2006 | 145 |
| 2007 | 114 |
| 2008 | 147 |
| 2009 | 148 |
| 2010 | 113 |
| 2011 | 107 |
| 2012 | 103 |
| 2013 | 112 |
| 2014 | 106 |
| 2015 | 125 |
| 2016 | 145 |
| 2017 | 158 |
| 2018 | 152 |
| 2019 | 119 |
| 2020 | 107 |
| 2021 | 95 |
| 2022 | 64 |
| 2023 | 39 |
| 2024 | 34 |
| 2025 | 14 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,779 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 108 |
| National Cancer Institute (NCI) | 99 |
| AstraZeneca | 93 |
| Hoffmann-La Roche | 66 |
| Pfizer | 64 |
| Alliance for Clinical Trials in Oncology | 53 |
| Boehringer Ingelheim | 51 |
| M.D. Anderson Cancer Center | 49 |
| Bristol-Myers Squibb | 46 |
| Memorial Sloan Kettering Cancer Center | 43 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 2,779 |
| Lung Neoplasms | 852 |
| Neoplasms | 211 |
| Breast Neoplasms | 183 |
| Small Cell Lung Carcinoma | 175 |
| Colorectal Neoplasms | 146 |
| Melanoma | 140 |
| Adenocarcinoma of Lung | 137 |
| Pancreatic Neoplasms | 124 |
| Neoplasm Metastasis | 123 |
Trials
Showing 51 to 75 of 2,779. Each trial links to its page on Pharma Observatory.
2,679 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.